{"filing":{"accession_number":"0001193125-26-401050","cik":"0001572616","ticker":"GUTS","company_name":"FRACTYL HEALTH, INC.","form":"8-K","filing_date":"2026-09-24","report_date":"2026-09-24","primary_document":"guts-20260924.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526401050/guts-20260924.htm"},"events":[{"id":34891,"run_id":32126,"accession_number":"0001193125-26-401050","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder vote results from a Special Meeting held on September 24, 2026. The filing reports the outcome of Proposal No. 1 regarding approval of a reverse stock split (1-for-5 to 1-for-15 ratio) at the Company's discretion, with 102.5 million votes in favor, 9.3 million against, and 191,821 abstentions. The reverse stock split is material to investors as it affects share structure and is typically undertaken to address delisting risk or improve stock price perception.","company_name":"FRACTYL HEALTH, INC.","ticker":"GUTS","filing_date":"2026-09-24","form":"8-K","submitted_at":null,"items":[{"id":38755,"accession_number":"0001193125-26-401050","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a Special Meeting held on September 24, 2026. The filing reports the outcome of Proposal No. 1 regarding approval of a reverse stock split (1-for-5 to 1-for-15 ratio) at the Company's discretion, with 102.5 million votes in favor, 9.3 million against, and 191,821 abstentions. The reverse stock split is material to investors as it affects share structure and is typically undertaken to address delisting risk or improve stock price perception.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:17:09.813769+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38755,"accession_number":"0001193125-26-401050","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a Special Meeting held on September 24, 2026. The filing reports the outcome of Proposal No. 1 regarding approval of a reverse stock split (1-for-5 to 1-for-15 ratio) at the Company's discretion, with 102.5 million votes in favor, 9.3 million against, and 191,821 abstentions. The reverse stock split is material to investors as it affects share structure and is typically undertaken to address delisting risk or improve stock price perception.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:17:09.813769+00:00","company_name":"FRACTYL HEALTH, INC.","ticker":"GUTS","filing_date":"2026-09-24"}]}